Mark Jeffrey DeLong, Chief Business & Strat Officer: Apellis Pharmaceuticals APLS Sell · Filed 01/23

Trade details

Type: Insider sale
Amount: $73,386.67
Shares · price: 3,371 sh · $21.77 a share
Held after: 78,353 sh
Stock: Apellis Pharmaceuticals APLS
Person: Mark Jeffrey DeLongChief Business & Strat Officer
Trade date: 26/01/22
Filed: 26/01/23
Days to filing: 1 days

Sold 4.1% of holdings

Share of holding sold: 4.1%

Apellis Pharmaceuticals trades, last 26 weeks

What else happened in Apellis Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/12/23~02/21

Mark Jeffrey DeLong's recent trades

Mark Jeffrey DeLongChief Business & Strat Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$8,151
368 sh
$8,151
Filed 02/13
Traded 02/11
Mark Jeffrey DeLongChief Business & Strat Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$26.4K
1,334 sh
$26.4K
Filed 01/21
Traded 01/20
Mark Jeffrey DeLongChief Business & Strat Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$39.5K
1,780 sh
$39.5K
Filed 01/15
Traded 01/13
Mark Jeffrey DeLongChief Business & Strat Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$10.4K
363 sh
$10.4K
Filed 25/02/12
Traded 25/02/11
Mark Jeffrey DeLongChief Business & Strat Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$10.8K
365 sh
$10.8K
Filed 25/01/30
Traded 25/01/29